Karyopharm Therapeutics Inc. Other Current Assets
Karyopharm Therapeutics Inc. (KPTI) had Other Current Assets of $31.47 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2022-11-03
- 2022-09-30: Other Assets, Current $31.47M.
- 2022-06-30: Other Assets, Current $32.08M.
- 2022-03-31: Other Assets, Current $29.14M.
- 2021-12-31: Other Assets, Current $1.53M.
| Period end | Other Assets, Current |
|---|---|
| 2022-09-30 | $31.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $32.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $29.14M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.53M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |